Navigation Links
Keppra XR(TM) Extended-Release Tablets Filed with the FDA
Date:1/16/2008

U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for the use of Keppra XR(TM) (levetiracetam) in the adjunctive treatment of partial onset seizures in adults with epilepsy

ATLANTA, Jan. 16 /PRNewswire/ -- UCB announced today that the New Drug Application (NDA) for the use of Keppra XR(TM) (levetiracetam) extended- release tablets in the adjunctive treatment of partial onset seizures in adults with epilepsy has been accepted for filing by the U.S. Food and Drug Administration (FDA).

"This filing is another important step in the development of UCB's epilepsy franchise and demonstrates our commitment to bringing new and innovative therapies to the epilepsy community," said Iris Loew-Friedrich, MD, PhD, Global Head of Development, UCB Group. "There is an ongoing need for new antiepileptic drug options without the limitations of twice daily dosing. Epilepsy therapies with more convenient dosing schedules may help encourage greater patient compliance, which is important to effective seizure control."

The filing for Keppra XR(TM) is supported by a Phase III, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of extended-release levetiracetam tablets (2x500 mg) once-daily as adjunctive therapy in 158 refractory epilepsy patients, 12 to 70 years of age, with partial onset seizures.

The study met its primary endpoint for seizure reduction over placebo during the treatment period (p=0.038). The median percent reduction of partial onset seizures in the extended-release levetiracetam group was 46.1% compared to 33.4% with placebo during the 12 week treatment period. Additionally, 24.0% of patients randomized to the extended-release levetiracetam group had seizure frequency per week reduced by 75-100%, compared with 11.4% of patients in the placebo group. In the extended-release levetiracetam group 10.1% of patients had 100% reduction i
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
2. SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
3. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
4. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
5. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015 Sanomedics , Inc. ... medical technology company that focuses on providing game ... the Company,s subsidiary, Thermomedics, Inc. , has appointed ... Government Sales. LeBel will be reporting to ... and will be responsible for supporting assigned distributor ...
(Date:3/4/2015)... March 4, 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of proprietary compounded drug therapies, today ... fiscal year 2014 financial results on Thursday, March 12, ... 4:30 p.m. EDT (1:30 p.m. PDT) on the same ... recent business activities.  The conference call and webcast will ...
(Date:3/4/2015)... 2015   Mallinckrodt plc (NYSE: ... at the Barclays Global Healthcare Conference at the Loews ... on Wednesday, March 11, 2015. Mark Trudeau, President and Chief ... a session scheduled to begin at 10:45 a.m. Eastern. ... person can find webcast information on Mallinckrodt,s Investor ...
Breaking Medicine Technology:Sanomedics Hires Scott W. LeBel as Director of Specialty and Government Sales 2Sanomedics Hires Scott W. LeBel as Director of Specialty and Government Sales 3Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 3Mallinckrodt to Present at Barclays Conference March 11 2
... LONDON, Aug. 31 Following a recent analysis ... Sullivan presented Lodox Systems (Pty) Ltd (Lodox) with ... Leadership Award".  Statscan, Lodox,s digital x-ray product, stunned ... diagnostic, whole-body x-ray pictures in just 13 seconds. ...
... PARK, N.C., and ALISO VIEJO, Calif., Aug. 30 GlaxoSmithKline ... VRX ) announced today the U.S. Food and ... Act (PDUFA) goal date for ezogabine* to 30 November 2010. ... The FDA has not yet completed the review of ...
Cached Medicine Technology:Frost & Sullivan Applauds the Lodox Statscan Critical Imaging System for Outperforming All Competing Products 2Frost & Sullivan Applauds the Lodox Statscan Critical Imaging System for Outperforming All Competing Products 3Frost & Sullivan Applauds the Lodox Statscan Critical Imaging System for Outperforming All Competing Products 4GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine 2GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine 3
(Date:3/4/2015)... 2015 With the growing influence of movies, ... our teens and young adults, combined with the increasingly frantic ... to try to keep up with what kids are into ... is replaced on a daily basis. , The same is ... slang that is used to discreetly talk about them, are ...
(Date:3/4/2015)... March 04, 2015 Starting February 2015, ... and PRK procedures at their new location in Surrey. ... Joseph King and Dr. Gabriel Chu also provide comprehensive ... Surrey is named Fraser Valley Cataract and Laser (FVCL). ... by the College of Physicians and Surgeons of British ...
(Date:3/4/2015)... March 04, 2015 The print component ... The San Francisco Chronicle with a circulation of approximately ... Its digital component is distributed nationally through a vast ... news sites and partner outlets. To explore the digital ... , Milorganite is composed of heat-dried microbes that have ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 As ... Endometriosis can be a painful condition in ... spreading outside of the uterus leading to very unpleasant ... families. Endometriosis can have a terrible effect on women’s ... is also the most common cause of infertility in ...
(Date:3/4/2015)... March 04, 2015 The popular all-natural ... their new L-Style Revolution™ Program. The customized program provides ... women of all health and fitness levels to follow ... faster than traditional methods. , “We’re really proud to ... plans based on award winning techniques to help people ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2Health News:King LASIK relocates to Surrey, British Columbia 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2
... a charge on cancer patients for powerful, intravenous medications, ... seriously considered by Ontario's Health Minister. ,George Smitherman ... due diligence and obviously we're closer to having a ... right thing said in a telephone interview yesterday. I ...
... Stroke Association has released a set of new recommendations ... published in the rapid access issue of Stroke: Journal ... third leading cause of death and a major source ... 700,000 people in the United States suffer a stroke, ...
... College of Midwives has revealed that most mothers prefer their ... of the 1400 female respondents said they would opt for ... in four fathers who were inside the delivery room felt ... in six mothers felt their husbands presence to be a ...
... hours for medical subjects such as anatomy in Australian ... medical students are unable to locate vital body parts//. ... with another. In addition to the subject of anatomy, ... hours for biochemistry, pathology, physiology and other basic sciences. ...
... (HLL), has launched the Female Condom (FC) in India. It ... Health Company to market// their female condoms in India under ... years of research before being able to launch the condom ... in the first year. A pair of Confidom will cost ...
... gaining popularity among the teenagers in the recent years. But ... deny bluntly that they ever took such vows. // ... are a good way of gauging how well they adhere ... take the form of public or written declarations to remain ...
Cached Medicine News:Health News:How To Prevent A Stroke 2Health News:How To Prevent A Stroke 3Health News:How To Prevent A Stroke 4Health News:Australian Medical Students Lack Anatomy Knowledge 2Health News:Teenagers Often Deny Taken ‘Virginity Pledges 2
A professionally designed instrument for obtaining accurate measurements of the corneal curvature. The convenient configuration also facilitates measuring contact lens curvatures....
... who need to move their imaging system from ... solution. The IMAGEnet Portable System features a rugged ... monitor. This portable PC solution can be coupled ... be tailored to your multi-site imaging needs. The ...
... 32-bit software package (IMAGEnet 2000) with the ... you a fast reliable solution to in-office ... of the Compaq EN Series small business ... and a formidable grouping of other top ...
... Topcon combines the best 32-bit software ... name hardware offerings to bring you a ... This cost efficient "mid-resolution" package takes advantage ... computer, adds the latest graphics capture technology ...
Medicine Products: